Replies to post #184579 on Anavex Life Sciences Corp (AVXL)

[Biostockclub]

I believe Anavex had revision/review/editorial license over the printed article, same as you, blue.

I think our CEO/company retains very tight control over what is released. That’s why I think it would have been unusual for them to ok such a groundbreaking release of info - the MoA of our drug, no less, without the complete best interest of the company in mind.

As Xena states, I’m sure this helps our case tremendously! I just don’t think we would allow it out there if we were working “without a net”. (Annette who???)

Just my opinion of strategy. Maybe I’m more cautious than M, but that seems like a stretch after such a lengthy ordeal of discipline when folks were calling for his dismissal - he never flinched or caved.

I don’t think he cares about boosting the SP daily short term, but I do think he cares about adding value to the company which will remain WITH the company and about bringing our drug(s) to market successfully and beneficially for treatment of these diseases.

I think the same can be said for all longs - we want the best all around. Win - win - win scenario.

Thanks for weighing in and I hope a short amount of time will bear us all out.
Bio